NL300805I2 - - Google Patents

Download PDF

Info

Publication number
NL300805I2
NL300805I2 NL300805C NL300805C NL300805I2 NL 300805 I2 NL300805 I2 NL 300805I2 NL 300805 C NL300805 C NL 300805C NL 300805 C NL300805 C NL 300805C NL 300805 I2 NL300805 I2 NL 300805I2
Authority
NL
Netherlands
Application number
NL300805C
Other languages
Dutch (nl)
Original Assignee
Onyx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/106,879 external-priority patent/US7232818B2/en
Application filed by Onyx Therapeutics Inc filed Critical Onyx Therapeutics Inc
Publication of NL300805I2 publication Critical patent/NL300805I2/nl

Links

NL300805C 2004-08-06 2016-04-29 NL300805I2 (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59940104P 2004-08-06 2004-08-06
US1040404P 2004-09-14 2004-09-14
US11/106,879 US7232818B2 (en) 2004-04-15 2005-04-14 Compounds for enzyme inhibition

Publications (1)

Publication Number Publication Date
NL300805I2 true NL300805I2 (lt) 2016-07-05

Family

ID=56740686

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300805C NL300805I2 (lt) 2004-08-06 2016-04-29

Country Status (1)

Country Link
NL (1) NL300805I2 (lt)

Similar Documents

Publication Publication Date Title
BE2024C508I2 (lt)
BE2022C549I2 (lt)
BE2024C511I2 (lt)
BE2020C513I2 (lt)
BE2020C517I2 (lt)
BE2019C540I2 (lt)
BE2019C548I2 (lt)
BE2018C045I2 (lt)
BE2017C027I2 (lt)
BE2017C023I2 (lt)
BE2017C002I2 (lt)
BE2016C067I2 (lt)
BE2016C014I2 (lt)
BE2015C038I2 (lt)
BE2015C066I2 (lt)
BE2015C014I2 (lt)
BE2014C071I2 (lt)
BE2014C064I2 (lt)
BE2019C535I2 (lt)
BE2015C065I2 (lt)
BR122015024347A2 (lt)
BRPI0508002A (lt)
JP2005223582A5 (lt)
BE2016C042I2 (lt)
BE2015C012I2 (lt)